PM
Praveen Mujumdar Gurunath Rao
About Praveen Mujumdar Gurunath Rao
Praveen Mujumdar Gurunath Rao has 4 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 4 companies, including Chethana Pharma Distributors Private Limited and Chethana Healthcare Solutions Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Chethana Pharma Distributors Private Limited
U51909KA2020PTC133694
|
Director | 09 Feb 2022 | 2020 | Active |
|
Chethana Healthcare Solutions Private Limited
U51909KA2019PTC122804
|
Director | 19 Oct 2023 | 2019 | Active |
|
Chirag Medicare Solutions Private Limited
U51909KA2019PTC122808
|
Whole-Time Director | 16 Nov 2023 | 2019 | Active |
|
Chethana Pharma Private Limited
U51909KA2019PTC123150
|
Director | 19 Oct 2023 | 2019 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Praveen Mujumdar Gurunath Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Praveen Mujumdar Gurunath Rao
Praveen Mujumdar Gurunath Rao has 4 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 4 companies, including Chethana Pharma Distributors Private Limited and Chethana Healthcare Solutions Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Praveen Mujumdar Gurunath Rao is associated with 4 companies as Director and Whole-Time Director.
Praveen Mujumdar Gurunath Rao has expertise in General Business, Healthcare.
Praveen Mujumdar Gurunath Rao has 4 years in corporate governance.